PI: Rory Johnson
Our mission is to develop new treatments for common diseases based on RNA therapeutics. In particular, we develop oligonucleotide drugs targeting cancer-causing long non-coding RNAs (lncRNAs), which we discover using CRISPR-Cas genome-editing and bioinformatics.
We are an interdisciplinary research group based at University College Dublin, and funded by Science Foundation Ireland through the 'Future Research Leaders' programme.
For more information go to Projects
We use genome-editing and bioinformatics to create (non-coding) RNA therapeutics.